• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Cidara Touts Positive Phase II Antifungal Data biospace
    March 20, 2018
    Shares of Cidara Therapeutics have fallen more than 22 percent this morning despite the company reporting its mid-stage antifungal candidate hit its primary endpoints and is on track to begin Phase III testing later this year.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service